These consultations relate to topics that are not necessarily connected to the identification of candidates for substitution or to the derogations concerning the exclusion criteria for the approval of active substances. These consultations are launched, for example, in the context of Article 75 (1) (g) mandates from the European Commission.

• Current consultations